4basebio (XTER:88Q) Moat Score: 0/10 (As of Jul. 15, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTER:88Q 4basebio PLC XTER:88Q
64 GF Score
Price €5.90
GF Value €31.00
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is 4basebio Moat Score?

4basebio has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

4basebio has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes 4basebio might have No Moat - No discernible moat.

4basebio  (XTER:88Q) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

4basebio Moat Score Related Terms

XTER:88Q
64GF Score
4basebio PLC XTER:88Q
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is 4basebio (XTER:88Q) Overvalued in 2026?

Based on GuruFocus' analysis, 4basebio stock appears to be undervalued. The current stock price of €5.90 is trading 81% below its estimated GF Value™ of €31.00. GuruFocus considers 4basebio to be Possible Value Trap.

Key valuation signals for XTER:88Q:

  • Moat Score: 0
  • GF Value™: €31.00 vs. price of €5.90 (81% below fair value)
  • GF Score™: 64/100 with 7 warning signs

No single metric tells the full story. See the XTER:88Q stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

4basebio Business Description

Other Exchanges 4BB:UK
Address 25 Norman Way, Over, Cambridge, GBR, CB24 5QE
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effectively and safely delivering these DNA-based products to patients. The company operates across three geographic segments: Europe, the United States, and the Rest of the World, with the majority of its revenue generated from the United States.
64GF Score

Get the complete analysis for XTER:88Q

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.90
Price
€31.00
GF Value